4
Apr
2019
Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer
GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a... Read More
9
May
2018
Fighting cancer is a team effort
/
By Dr. Peter A. Jones and Dr. Steve Baylin Co-leaders, Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team
21
Dec
2017
10 highlights: A look back at 2017
With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s... Read More
30
Nov
2017
Clinical trial investigates possible triple threat for lung cancer
/
A first-of-its-kind combination of medications may enable the immune system to better combat lung cancer, which claims more lives than any other... Read More
28
Jan
2016
Phase II colorectal cancer clinical trial first to receive support, scientific oversight from Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team
/
GRAND RAPIDS, Mich. (Jan. 28, 2016)—The first clinical trial to move forward as part of the Van Andel Research Institute–Stand Up To... Read More
26
Feb
2015
Van Andel Research Institute appoints leading cancer scientist Dr. Stephen Baylin as professor
/
GRAND RAPIDS, Mich. (Feb. 26, 2015)—Renowned cancer scientist and epigenetics expert Stephen Baylin, M.D., has accepted an appointment at Van Andel Research Institute... Read More
20
Oct
2014
Stand Up To Cancer Epigenetics Dream Team continues with $7.5 million funding from Van Andel Research Institute
/
Grand Rapids, Michigan (October 20, 2014)— The work of one of the Stand Up To Cancer (SU2C) inaugural Dream Teams, launched in... Read More